EntryPoint Capital’s CareDx CDNA Stock Holding History

EntryPoint Capital’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,940	Closed	-$188K	–	679
2025 Q3	$188K	Buy	+12,940	New	+$184K	0.07%	561
2025 Q2	–	Sell	-11,308	Closed	-$201K	–	637
2025 Q1	$201K	Sell	11,308 -5,214	-32%	-$112K	0.09%	541
2024 Q4	$354K	Buy	16,522 +4,182	+34%	+$102K	0.15%	272
2024 Q3	$385K	Buy	12,340 +8,813	+250%	+$219K	0.22%	142
2024 Q2	$54.8K	Buy	+3,527	New	+$42.6K	0.08%	530

Other funds holding CDNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

EntryPoint Capital's CDNA Position: Q4 2025 in Review

EntryPoint Capital sold out of CareDx (CDNA) in Q4 2025, closing a stake of 12,940 shares — an estimated $188K sold.

EntryPoint Capital first reported a position in CDNA in Q2 2024 and held it in 5 quarters. The position peaked at $385K in Q3 2024. 200 funds tracked by Wall St. Rank hold CDNA as of Q4 2025.

EntryPoint Capital reported no remaining CareDx position as of Q4 2025 after selling out during the quarter.
EntryPoint Capital sold 12,940 CareDx shares in Q4 2025, an estimated $188K.
EntryPoint Capital first reported a position in CareDx in Q2 2024 and held it in 5 quarters.
EntryPoint Capital's CareDx position peaked at $385K in Q3 2024.
200 funds tracked by Wall St. Rank held CareDx as of Q4 2025.

Based on EntryPoint Capital's 13F filing for Q4 2025, filed 12 Feb 2026.